US Patent Issued to Myriad Genetics, The Board of Regents of the University of Texas System on April 7 for "Methods and materials for assessing loss of heterozygosity" (Utah Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,513, issued on April 7, was assigned to Myriad Genetics Inc. (Salt Lake City) and The Board of Regents of the University of Texas System (Austin, Texas).

"Methods and materials for assessing loss of heterozygosity" was invented by Victor Abkevich (Salt Lake City), Alexander Gutin (Salt Lake City), Kirsten Timms (Salt Lake City) and Jerry Lanchbury (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature. For example, methods and materials for determining whether or not a cell (e.g., a canc...